These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25854863)

  • 21. Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.
    Ruwald MH; Xu Parks X; Moss AJ; Zareba W; Baman J; McNitt S; Kanters JK; Shimizu W; Wilde AA; Jons C; Lopes CM
    Heart Rhythm; 2016 Jan; 13(1):122-31. PubMed ID: 26318259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?
    Crotti L; Lahtinen AM; Spazzolini C; Mastantuono E; Monti MC; Morassutto C; Parati G; Heradien M; Goosen A; Lichtner P; Meitinger T; Brink PA; Kontula K; Swan H; Schwartz PJ
    Circ Cardiovasc Genet; 2016 Aug; 9(4):330-9. PubMed ID: 27531917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.
    Thomas D; Wimmer AB; Karle CA; Licka M; Alter M; Khalil M; Ulmer HE; Kathöfer S; Kiehn J; Katus HA; Schoels W; Koenen M; Zehelein J
    Cardiovasc Res; 2005 Aug; 67(3):487-97. PubMed ID: 15950200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third trimester fetal heart rate predicts phenotype and mutation burden in the type 1 long QT syndrome.
    Winbo A; Fosdal I; Lindh M; Diamant UB; Persson J; Wettrell G; Rydberg A
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):806-14. PubMed ID: 26019114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression-Replacement
    Dotzler SM; Kim CSJ; Gendron WAC; Zhou W; Ye D; Bos JM; Tester DJ; Barry MA; Ackerman MJ
    Circulation; 2021 Apr; 143(14):1411-1425. PubMed ID: 33504163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1.
    Kapplinger JD; Erickson A; Asuri S; Tester DJ; McIntosh S; Kerr CR; Morrison J; Tang A; Sanatani S; Arbour L; Ackerman MJ
    J Med Genet; 2017 Jun; 54(6):390-398. PubMed ID: 28264985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome.
    Bains S; Dotzler SM; Krijger C; Giudicessi JR; Ye D; Bikker H; Rohatgi RK; Tester DJ; Bos JM; Wilde AAM; Ackerman MJ
    Heart Rhythm; 2022 Mar; 19(3):435-442. PubMed ID: 34798354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.
    Koponen M; Marjamaa A; Hiippala A; Happonen JM; Havulinna AS; Salomaa V; Lahtinen AM; Hintsa T; Viitasalo M; Toivonen L; Kontula K; Swan H
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):815-23. PubMed ID: 26063740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
    Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
    Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.
    Amin AS; Giudicessi JR; Tijsen AJ; Spanjaart AM; Reckman YJ; Klemens CA; Tanck MW; Kapplinger JD; Hofman N; Sinner MF; Müller M; Wijnen WJ; Tan HL; Bezzina CR; Creemers EE; Wilde AA; Ackerman MJ; Pinto YM
    Eur Heart J; 2012 Mar; 33(6):714-23. PubMed ID: 22199116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterisation of a novel KCNQ1 mutation in a family with Romano-Ward syndrome.
    Zehelein J; Thomas D; Khalil M; Wimmer AB; Koenen M; Licka M; Wu K; Kiehn J; Brockmeier K; Kreye VA; Karle CA; Katus HA; Ulmer HE; Schoels W
    Biochim Biophys Acta; 2004 Nov; 1690(3):185-92. PubMed ID: 15511625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval.
    Lundby A; Ravn LS; Svendsen JH; Olesen SP; Schmitt N
    Heart Rhythm; 2007 Dec; 4(12):1532-41. PubMed ID: 17997361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.
    Hoefen R; Reumann M; Goldenberg I; Moss AJ; O-Uchi J; Gu Y; McNitt S; Zareba W; Jons C; Kanters JK; Platonov PG; Shimizu W; Wilde AA; Rice JJ; Lopes CM
    J Am Coll Cardiol; 2012 Nov; 60(21):2182-91. PubMed ID: 23153844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease characterization using LQTS-specific induced pluripotent stem cells.
    Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
    Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassuring News for Genetically Tested, Appropriately Treated, Low-Risk LQTS Patients.
    Lampert R
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):859-861. PubMed ID: 26031829
    [No Abstract]   [Full Text] [Related]  

  • 39. How does KCNE1 regulate the Kv7.1 potassium channel? Model-structure, mutations, and dynamics of the Kv7.1-KCNE1 complex.
    Gofman Y; Shats S; Attali B; Haliloglu T; Ben-Tal N
    Structure; 2012 Aug; 20(8):1343-52. PubMed ID: 22771213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LQT1-associated mutations increase KCNQ1 proteasomal degradation independently of Derlin-1.
    Peroz D; Dahimène S; Baró I; Loussouarn G; Mérot J
    J Biol Chem; 2009 Feb; 284(8):5250-6. PubMed ID: 19114714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.